Log in
Enquire now

List of SBIR/STTR awards granted to APT Therapeutics

List of SBIR/STTR awards granted to APT Therapeutics
List of SBIR/STTR awards granted to ARXAN RESEARCH, INC.
List of SBIR/STTR awards granted to Translume
List of SBIR/STTR awards granted to AMBION DIAGNOSTICS, INC.
List of Idexx Laboratories patents
List of Calor patents
where
SBIR/STTR Award Recipient
is
APT TherapeuticsAPT Therapeutics
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
APT THERAPEUTICS, INC. SBIR Phase II Award, April 2017

A SBIR Phase II contract was awarded to APT Therapeutics in April, 2017 for $1,902,274.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R44HL135993-01
Phase II
1,902,274
April 18, 2017
sbir.gov/node/1692303
‌
APT THERAPEUTICS, INC. SBIR Phase II Award, September 2021

A SBIR Phase II contract was awarded to APT Therapeutics in September, 2021 for $996,399.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
2R44NS106850-02
Phase II
996,399
September 20, 2021
sbir.gov/node/2192243
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2020

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43DK126493-01A1
Phase I
300,000
September 15, 2020
sbir.gov/node/1916831
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2019

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2019 for $344,933.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43NS113641-01
Phase I
344,933
September 15, 2019
sbir.gov/node/1683331
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2018

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2018 for $337,602.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43HL140699-01A1
Phase I
337,602
September 1, 2018
sbir.gov/node/1573603
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2018

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2018 for $299,346.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43NS106850-01
Phase I
299,346
September 1, 2018
sbir.gov/node/1566529
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, June 2021

A SBIR Phase I contract was awarded to APT Therapeutics in June, 2021 for $259,576.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43AR079294-01
Phase I
259,576
June 5, 2021
sbir.gov/node/2186775
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, April 2018

A SBIR Phase I contract was awarded to APT Therapeutics in April, 2018 for $299,794.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43CA228319-01
Phase I
299,794
April 16, 2018
sbir.gov/node/1566511
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2019

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

APT Therapeutics
APT Therapeutics
National Institutes of Health
National Institutes of Health
SBIR
1R43CA246779-01
Phase I
300,000
September 18, 2019
sbir.gov/node/1685927
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2016

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43AR070662-01A1
Phase I
225,000
September 14, 2016
sbir.gov/node/1196939
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2015

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2015 for $298,486.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43DK108315-01
Phase I
298,486
September 20, 2015
sbir.gov/node/1030477
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, May 2016

A SBIR Phase I contract was awarded to APT Therapeutics in May, 2016 for $299,200.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43DK109749-01
Phase I
299,200
May 1, 2016
sbir.gov/node/1163837
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2015

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2015 for $297,410.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43HL126212-01
Phase I
297,410
September 1, 2015
sbir.gov/node/1030715
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, August 2016

A SBIR Phase I contract was awarded to APT Therapeutics in August, 2016 for $2,736,786.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
2SB1NS060175-04
Phase I
2,736,786
August 1, 2016
sbir.gov/node/1324937
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, September 2017

A SBIR Phase I contract was awarded to APT Therapeutics in September, 2017 for $279,040.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43DK113815-01
Phase I
279,040
September 15, 2017
sbir.gov/node/1322957
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, April 2017

A SBIR Phase I contract was awarded to APT Therapeutics in April, 2017 for $300,437.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R44HL135993-01
Phase I
300,437
April 18, 2017
sbir.gov/node/1306379
‌
APT THERAPEUTICS, INC. SBIR Phase I Award, August 2015

A SBIR Phase I contract was awarded to APT Therapeutics in August, 2015 for $299,793.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43NS093684-01
Phase I
299,793
August 1, 2015
sbir.gov/node/1045771
‌
APT THERAPEUTICS, INC. SBIR Phase II Award, August 2016

A SBIR Phase II contract was awarded to APT Therapeutics in August, 2016 for $2,999,301.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
2SB1NS060175-04
Phase II
2,999,301
August 1, 2016
sbir.gov/node/1199495
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $281,598.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43HL115860-01
Phase I
281,598
sbir.gov/node/400862
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $287,622.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43NS071655-01
Phase I
287,622
sbir.gov/node/1897
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $196,745.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43CA130192-01A2
Phase I
196,745
sbir.gov/content/human-apyrase-disrupt-cancer-therapy-0
‌
APT THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to APT Therapeutics for $839,863.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
2R44HL087456-02
Phase II
839,863
sbir.gov/content/apyrase-treat-ischemiareperfusion-injury-during-lung-transplantation-2
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $224,879.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43NS088993-01
Phase I
224,879
sbir.gov/node/706319
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $187,435.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43NS060175-01
Phase I
187,435
sbir.gov/content/preclinical-validation-human-apyrase-stroke-models-0
‌
APT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to APT Therapeutics for $98,750.0 USD from the U.S. Department of Health & Human Services.

APT Therapeutics
APT Therapeutics
SBIR
1R43HL076053-01
Phase I
98,750
sbir.gov/content/production-human-cd39-antithrombotic-agent-0
Results per page:
33 results
0 selected
33 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us